Table 1

Characteristics of the groups of HIV-1–infected patients included in the study

GroupNo.SexLast CD4, median (range)*Last viral load, median (range)Months on HAART, median (range)
HIV controllers 55 M:31 F:24 680 (266-1665) < 40 (< 40-366) — 
HIV-1 viremics M:6 F:3 378 (278-654) 42984 (8048-116 266) — 
HAART treated 12 M:10 F:2 633 (292-886) < 40 (< 40-51) 45 (7-98) 
GroupNo.SexLast CD4, median (range)*Last viral load, median (range)Months on HAART, median (range)
HIV controllers 55 M:31 F:24 680 (266-1665) < 40 (< 40-366) — 
HIV-1 viremics M:6 F:3 378 (278-654) 42984 (8048-116 266) — 
HAART treated 12 M:10 F:2 633 (292-886) < 40 (< 40-51) 45 (7-98) 
*

Last CD4+ T-cell count/mm3 of blood.

HIV-1 RNA copies/mL of plasma with standard technique.

Months with successful HAART-related control of viremia before inclusion.

Close Modal

or Create an Account

Close Modal
Close Modal